| Year |
Citation |
Score |
| 2024 |
Forgie BN, Prakash R, Goyeneche AA, Telleria CM. Vitality, viability, long-term clonogenic survival, cytotoxicity, cytostasis and lethality: what do they mean when testing new investigational oncology drugs? Discover. Oncology. 15: 5. PMID 38180601 DOI: 10.1007/s12672-023-00857-2 |
0.367 |
|
| 2023 |
Abdalbari FH, Martinez-Jaramillo E, Forgie BN, Tran E, Zorychta E, Goyeneche AA, Sabri S, Telleria CM. Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells. Cancers. 15. PMID 37958311 DOI: 10.3390/cancers15215136 |
0.37 |
|
| 2023 |
Prakash R, Telleria CM. Cancer cell repopulation after therapy: which is the mechanism? Oncoscience. 10: 14-19. PMID 37273928 DOI: 10.18632/oncoscience.577 |
0.482 |
|
| 2022 |
Ritch SJ, Noman ASM, Goyeneche AA, Telleria CM. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone. Cancer Cell International. 22: 397. PMID 36494669 DOI: 10.1186/s12935-022-02822-5 |
0.446 |
|
| 2022 |
Ritch SJ, Telleria CM. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination. Frontiers in Endocrinology. 13: 886533. PMID 35574025 DOI: 10.3389/fendo.2022.886533 |
0.475 |
|
| 2021 |
Abdalbari FH, Telleria CM. The gold complex auranofin: new perspectives for cancer therapy. Discover. Oncology. 12: 42. PMID 35201489 DOI: 10.1007/s12672-021-00439-0 |
0.473 |
|
| 2021 |
Subeha MR, Goyeneche AA, Bustamante P, Lisio MA, Burnier JV, Telleria CM. Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition. Cancers. 14. PMID 35008264 DOI: 10.3390/cancers14010099 |
0.406 |
|
| 2020 |
Subeha MR, Telleria CM. The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir. Cancers. 12. PMID 33228205 DOI: 10.3390/cancers12113437 |
0.322 |
|
| 2020 |
Goyeneche A, Lisio MA, Fu L, Srinivasan R, Valdez Capuccino J, Gao ZH, Telleria C. The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice. Cancers. 12. PMID 32188032 DOI: 10.3390/cancers12030699 |
0.417 |
|
| 2019 |
Ferreira SR, Goyeneche AA, Heber MF, Abruzzese GA, Telleria CM, Motta AB. Prenatally androgenized female rats develop uterine hyperplasia when adult. Molecular and Cellular Endocrinology. 110610. PMID 31589912 DOI: 10.1016/j.mce.2019.110610 |
0.308 |
|
| 2019 |
Ritch SJ, Brandhagen BN, Goyeneche AA, Telleria CM. Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling. Bmc Cancer. 19: 376. PMID 31014286 DOI: 10.1186/s12885-019-5587-3 |
0.775 |
|
| 2019 |
Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints. International Journal of Molecular Sciences. 20. PMID 30813239 DOI: 10.3390/ijms20040952 |
0.317 |
|
| 2019 |
Goyeneche AA, Lisio MA, Gao Z, Telleria CM. Abstract 1950: Differential expression of MUC16 mucin (CA125) depending on the architecture of the tumors developed in an orthotopic mouse model of high-grade serous ovarian cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1950 |
0.37 |
|
| 2018 |
Kapperman HE, Goyeneche AA, Telleria CM. Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin. Cancer Cell International. 18: 185. PMID 30479564 DOI: 10.1186/s12935-018-0683-z |
0.355 |
|
| 2017 |
Vallcaneras SS, de la Vega M, Delgado SM, Motta A, Telleria C, Rastrilla AM, Casais M. Prolactin modulates luteal regression from the coeliac ganglion via the superior ovarian nerve in the late-pregnant rat. Reproduction, Fertility, and Development. 28: 565-73. PMID 25194502 DOI: 10.1071/Rd14184 |
0.313 |
|
| 2017 |
Goyeneche AA, Gao Z, Telleria CM. Abstract 795: The capacity of high-grade serous ovarian cancer cells to form spontaneous multicellular structures (SMCS)in vitropredicts theirin vivotumorigenicity Cancer Research. 77: 795-795. DOI: 10.1158/1538-7445.Am2017-795 |
0.53 |
|
| 2017 |
Alghamdi SS, Goyeneche AA, Gao Z, Telleria CM. Abstract 1979: Cell lines that genomically resemble high-grade serous ovarian carcinomas display differences in growth and invasive capacities in an orthometastatic nude mouse model Cancer Research. 77: 1979-1979. DOI: 10.1158/1538-7445.Am2017-1979 |
0.414 |
|
| 2016 |
Zhang L, Hapon MB, Goyeneche AA, Srinivasan R, Gamarra-Luques CD, Callegari EA, Drappeau DD, Terpstra EJ, Pan B, Knapp JR, Chien J, Wang X, Eyster KM, Telleria CM. Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors. Molecular Oncology. PMID 27233943 DOI: 10.1016/j.molonc.2016.05.001 |
0.472 |
|
| 2015 |
Goyeneche AA, Koch M, Bell MC, Telleria CM. Long-term primary culture of a clear cell ovarian carcinoma reveals an epithelial-mesenchymal cooperative interaction. Cancer Cell International. 15: 88. PMID 26405433 DOI: 10.1186/S12935-015-0243-8 |
0.387 |
|
| 2015 |
Ghersa F, Burdisso J, Vallcaneras SS, Fuentes F, de la Vega M, Delgado SM, Telleria CM, Casais M. Neuromodulation of the luteal regression: presence of progesterone receptors in coeliac ganglion. Experimental Physiology. 100: 935-46. PMID 26084725 DOI: 10.1113/Ep085261 |
0.335 |
|
| 2015 |
Goyeneche AA, Telleria CM. Antiprogestins in gynecological diseases. Reproduction (Cambridge, England). 149: R15-33. PMID 25252652 DOI: 10.1530/Rep-14-0416 |
0.459 |
|
| 2015 |
Goyeneche AA, Srinivasan R, Valdez JM, Telleria CM. Abstract 4205: Development of peritoneal carcinomatosis by multicellular structures of high-grade serous ovarian cancer Cancer Research. 75: 4205-4205. DOI: 10.1158/1538-7445.Am2015-4205 |
0.54 |
|
| 2015 |
Zhang L, Goyeneche A, Srinivasan R, Telleria C. Abstract 1255: Mifepristone causes endoplasmic reticulum stress, triggers the unfolded protein response, and increases autophagic flux in ovarian cancer cells Cancer Research. 75: 1255-1255. DOI: 10.1158/1538-7445.Am2015-1255 |
0.482 |
|
| 2014 |
Gamarra-Luques CD, Hapon MB, Goyeneche AA, Telleria CM. Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity. Journal of Ovarian Research. 7: 45. PMID 24795781 DOI: 10.1186/1757-2215-7-45 |
0.459 |
|
| 2014 |
Sane S, Abdullah A, Boudreau DA, Autenried RK, Gupta BK, Wang X, Wang H, Schlenker EH, Zhang D, Telleria C, Huang L, Chauhan SC, Rezvani K. Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells. Cell Death & Disease. 5: e1118. PMID 24625977 DOI: 10.1038/Cddis.2014.100 |
0.33 |
|
| 2013 |
Telleria CM. Repopulation of ovarian cancer cells after chemotherapy. Cancer Growth and Metastasis. 6: 15-21. PMID 23544004 DOI: 10.4137/CGM.S11333 |
0.461 |
|
| 2013 |
Wempe SL, Gamarra-Luques CD, Telleria CM. Synergistic lethality of mifepristone and LY294002 in ovarian cancer cells. Cancer Growth and Metastasis. 6: 1-13. PMID 23420486 DOI: 10.4137/CGM.S11124 |
0.55 |
|
| 2013 |
Brandhagen BN, Tieszen CR, Ulmer TM, Tracy MS, Goyeneche AA, Telleria CM. Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics Bmc Cancer. 13. PMID 23351358 DOI: 10.1186/1471-2407-13-35 |
0.784 |
|
| 2013 |
Vallcaneras SS, Delgado SM, Motta A, Telleria CM, Rastrilla AM, Casais M. Effect of prolactin acting on the coeliac ganglion via the superior ovarian nerve on ovarian function in the postpartum lactating and non-lactating rat. General and Comparative Endocrinology. 184: 1-8. PMID 23313075 DOI: 10.1016/J.Ygcen.2012.12.012 |
0.356 |
|
| 2013 |
Wempe SL, Gamarra-Luques CD, Telleria CM. Abstract 2098: Synergistic lethality of mifepristone and LY294002 in ovarian cancer cells. Cancer Research. 73: 2098-2098. DOI: 10.1158/1538-7445.Am2013-2098 |
0.627 |
|
| 2013 |
Hapon MB, Gamarra-Luques CD, Goyeneche AA, Callegari EA, Eyster KM, Telleria CM. Abstract A23: Induction of the unfolded protein response in ovarian cancer cells exposed to cytostatic concentrations of antiprogestin/antiglucocorticoid mifepristone Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A23 |
0.544 |
|
| 2013 |
Sereda G, Moorthy R, Gamarra-Luques C, Telleria C. Facile Synthesis of a Phototoxic Monofunctionalized Tetraarylporphyrin as Scaffold for Porphyrin-Quinone Conjugates Synthetic Communications. 43: 182-190. DOI: 10.1080/00397911.2011.594546 |
0.489 |
|
| 2012 |
Telleria CM. Drug Repurposing for Cancer Therapy. Journal of Cancer Science & Therapy. 4: ix-xi. PMID 22984635 DOI: 10.4172/1948-5956.1000E108 |
0.402 |
|
| 2012 |
Gamarra-Luques CD, Goyeneche AA, Hapon MB, Telleria CM. Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy. Bmc Cancer. 12: 200. PMID 22642877 DOI: 10.1186/1471-2407-12-200 |
0.552 |
|
| 2012 |
Casais M, Vallcaneras SS, Campo Verde Arbocco F, Delgado SM, Hapon MB, Sosa Z, Telleria CM, Rastrilla AM. Estradiol promotes luteal regression through a direct effect on the ovary and an indirect effect from the celiac ganglion via the superior ovarian nerve. Reproductive Sciences (Thousand Oaks, Calif.). 19: 416-22. PMID 22101240 DOI: 10.1177/1933719111424436 |
0.341 |
|
| 2012 |
Goyeneche AA, Seidel EE, Telleria CM. Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2. Investigational New Drugs. 30: 967-80. PMID 21424700 DOI: 10.1007/S10637-011-9655-Z |
0.51 |
|
| 2012 |
Goyeneche AA, Bell MC, Telleria CM. Abstract 4246: Long-term primary culture of a mucinous ovarian adenocarcinoma containing CD133 positive cells Cancer Research. 72: 4246-4246. DOI: 10.1158/1538-7445.Am2012-4246 |
0.553 |
|
| 2012 |
Brandhagen BN, Tracy MS, Goyeneche AA, Telleria CM. Abstract 344: Mifepristone alters morphology, cytoskeletal architecture, and epithelial-mesenchymal transition-related proteins in human metastatic cancer cells Cancer Research. 72: 344-344. DOI: 10.1158/1538-7445.Am2012-344 |
0.793 |
|
| 2011 |
López-Fontana CM, Maselli ME, de Di Nasso FE, Telleria CM, Carón RW. Regulation of prolactin secretion during the estrus in rats: possible role of glucocorticoids. Reproduction (Cambridge, England). 142: 477-85. PMID 21697336 DOI: 10.1530/Rep-11-0100 |
0.325 |
|
| 2011 |
Tieszen CR, Goyeneche AA, Brandhagen BN, Ortbahn CT, Telleria CM. Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression. Bmc Cancer. 11: 207. PMID 21619605 DOI: 10.1186/1471-2407-11-207 |
0.77 |
|
| 2011 |
Vallcaneras SS, Casais M, Anzulovich AC, Delgado SM, Sosa Z, Telleria CM, Rastrilla AM. Androstenedione acts on the coeliac ganglion and modulates luteal function via the superior ovarian nerve in the postpartum rat. The Journal of Steroid Biochemistry and Molecular Biology. 125: 243-50. PMID 21439382 DOI: 10.1016/J.Jsbmb.2011.03.017 |
0.309 |
|
| 2011 |
Tieszen CR, Goyeneche AA, Brandhagen BN, Telleria CM. Abstract 4546: Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression Cancer Research. 71: 4546-4546. DOI: 10.1158/1538-7445.Am2011-4546 |
0.792 |
|
| 2011 |
Gamarra-Luques CD, Hapon MB, Goyeneche AA, Telleria CM. Abstract 363: Antiprogestin mifepristone improves the efficacy of the combination therapy cisplatin/paclitaxel in human ovarian carcinoma cellsin vitro Cancer Research. 71: 363-363. DOI: 10.1158/1538-7445.Am2011-363 |
0.489 |
|
| 2011 |
Brandhagen BN, Tieszen CR, Telleria CM, Goyeneche AA. Abstract 2362: Antimetastatic potential of the antiprogestin mifepristone in cancer cells Cancer Research. 71: 2362-2362. DOI: 10.1158/1538-7445.Am2011-2362 |
0.789 |
|
| 2010 |
Goyeneche AA, Seidel EE, Telleria CM. Abstract 718: Antiprogestins are cytostatic at pharmacological concentrations and lethal at suprapharmacological concentrations to ovarian cancer cells Cancer Research. 70: 718-718. DOI: 10.1158/1538-7445.Am10-718 |
0.554 |
|
| 2010 |
Luques CG, Telleria CM. Abstract A113: Enhancement of the lethality of platinum-based therapy by antiprogestin mifepristone in ovarian cancer Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-A113 |
0.552 |
|
| 2009 |
Villavicencio A, Goyeneche A, Telleria C, Bacallao K, Gabler F, Fuentes A, Vega M. Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome. Gynecologic Oncology. 115: 102-7. PMID 19631369 DOI: 10.1016/J.Ygyno.2009.06.033 |
0.379 |
|
| 2009 |
Freeburg EM, Goyeneche AA, Seidel EE, Telleria CM. Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity. Cancer Cell International. 9: 4. PMID 19222856 DOI: 10.1186/1475-2867-9-4 |
0.622 |
|
| 2009 |
Freeburg EM, Goyeneche AA, Telleria CM. Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment. International Journal of Oncology. 34: 743-55. PMID 19212679 DOI: 10.3892/Ijo_00000200 |
0.629 |
|
| 2008 |
Freeburg EM, Goyeneche AA, Telleria CM. Abstract 1210: Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment Endocrinology. DOI: 10.1158/1538-7445.Am2008-1210 |
0.54 |
|
| 2007 |
Goyeneche AA, Carón RW, Telleria CM. Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3370-9. PMID 17545545 DOI: 10.1158/1078-0432.Ccr-07-0164 |
0.538 |
|
| 2007 |
Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocrine Reviews. 28: 117-49. PMID 17077191 DOI: 10.1210/Er.2006-0022 |
0.394 |
|
| 2006 |
Casais M, Delgado SM, Sosa Z, Telleria CM, Rastrilla AM. The celiac ganglion modulates LH-induced inhibition of androstenedione release in late pregnant rat ovaries. Reproductive Biology and Endocrinology : Rb&E. 4: 66. PMID 17184551 DOI: 10.1186/1477-7827-4-66 |
0.319 |
|
| 2006 |
Goyeneche AA, Harmon JM, Telleria CM. Cell death induced by serum deprivation in luteal cells involves the intrinsic pathway of apoptosis Reproduction. 131: 103-111. PMID 16388014 DOI: 10.1530/Rep.1.00751 |
0.469 |
|
| 2005 |
Goyeneche AA, Telleria CM. Exogenous estradiol enhances apoptosis in regressing post-partum rat corpora lutea possibly mediated by prolactin. Reproductive Biology and Endocrinology : Rb&E. 3: 40. PMID 16131396 DOI: 10.1186/1477-7827-3-40 |
0.362 |
|
| 2005 |
Telleria CM, Goyeneche AA, Stocco CO, Gibori G. Involvement of nuclear factor kappa B in the regulation of rat luteal function: potential roles as survival factor and inhibitor of 20alpha-hydroxysteroid dehydrogenase. Journal of Molecular Endocrinology. 32: 365-83. PMID 15072545 DOI: 10.1677/Jme.0.0320365 |
0.443 |
|
| 2003 |
Bowen-Shauver JM, Telleria CM. Luteal regression: a redefinition of the terms. Reproductive Biology and Endocrinology : Rb&E. 1: 28. PMID 12685929 DOI: 10.1186/1477-7827-1-28 |
0.332 |
|
| 2003 |
Goyeneche AA, Martinez IL, Deis RP, Gibori G, Telleria CM. In vivo hormonal environment leads to differential susceptibility of the corpus luteum to apoptosis in vitro. Biology of Reproduction. 68: 2322-30. PMID 12606365 DOI: 10.1095/Biolreprod.102.013540 |
0.425 |
|
| 2003 |
Tessier C, Prigent-Tessier A, Bao L, Telleria CM, Ferguson-Gottschall S, Gibori GB, Gu Y, Bowen-Shauver JM, Horseman ND, Gibori G. Decidual activin: its role in the apoptotic process and its regulation by prolactin. Biology of Reproduction. 68: 1687-94. PMID 12606360 DOI: 10.1095/Biolreprod.102.011684 |
0.461 |
|
| 2003 |
Goyeneche AA, Deis RP, Gibori G, Telleria CM. Progesterone promotes survival of the rat corpus luteum in the absence of cognate receptors. Biology of Reproduction. 68: 151-8. PMID 12493707 DOI: 10.1095/Biolreprod.102.007898 |
0.445 |
|
| 2002 |
Goyeneche AA, Calvo V, Gibori G, Telleria CM. Androstenedione interferes in luteal regression by inhibiting apoptosis and stimulating progesterone production. Biology of Reproduction. 66: 1540-7. PMID 11967221 DOI: 10.1095/Biolreprod66.5.1540 |
0.391 |
|
| 2002 |
Telleria CM, Goyeneche AA, Cavicchia JC, Stati AO, Deis RP. Apoptosis induced by antigestagen RU486 in rat corpus luteum of pregnancy. Endocrine. 15: 147-55. PMID 11720240 DOI: 10.1385/Endo:15:2:147 |
0.395 |
|
| 1999 |
Telleria CM, Stocco CO, Stati AO, Deis RP. Progesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy. Steroids. 64: 760-6. PMID 10577832 DOI: 10.1016/S0039-128X(99)00061-6 |
0.38 |
|
| 1999 |
Sugino N, Telleria CM, Tessier C, Gibori G. Regulation and role of the insulin-like growth factor I system in rat luteal cells. Journal of Reproduction and Fertility. 115: 349-55. PMID 10434941 DOI: 10.1530/Jrf.0.1150349 |
0.404 |
|
| 1998 |
Telleria CM, Zhong L, Deb S, Srivastava RK, Park KS, Sugino N, Park-Sarge OK, Gibori G. Differential Expression of the Estrogen Receptors α and β in the Rat Corpus Luteum of Pregnancy: Regulation by Prolactin and Placental Lactogens. Endocrinology. 139: 2432-2442. PMID 28204247 DOI: 10.1210/Endo.139.5.5974 |
0.324 |
|
| 1998 |
Sugino N, Hirosawa-Takamori M, Zhong L, Telleria CM, Shiota K, Gibori G. Hormonal regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase messenger ribonucleic acid in the rat corpus luteum: induction by prolactin and placental lactogens. Biology of Reproduction. 59: 599-605. PMID 9716559 DOI: 10.1095/Biolreprod59.3.599 |
0.368 |
|
| 1998 |
Telleria CM, Ou J, Sugino N, Ferguson S, Gibori G. The expression of interleukin-6 in the pregnant rat corpus luteum and its regulation by progesterone and glucocorticoid. Endocrinology. 139: 3597-605. PMID 9681513 DOI: 10.1210/Endo.139.8.6132 |
0.304 |
|
| 1998 |
Sugino N, Zilberstein M, Srivastava RK, Telleria CM, Nelson SE, Risk M, Chou JY, Gibori G. Establishment and characterization of a simian virus 40-transformed temperature-sensitive rat luteal cell line. Endocrinology. 139: 1936-42. PMID 9528980 DOI: 10.1210/Endo.139.4.5929 |
0.458 |
|
| 1998 |
Telleria CM, Mezzadri MR, Deis RP. Fertility impairment after mifepristone treatment to rats at proestrus. Actions on the hypothalamic-hypophyseal-ovarian axis. Contraception. 56: 267-74. PMID 9408709 DOI: 10.1016/S0010-7824(97)00137-6 |
0.319 |
|
| 1997 |
Telleria CM, Parmer TG, Zhong L, Clarke DL, Albarracin CT, Duan WR, Linzer DI, Gibori G. The different forms of the prolactin receptor in the rat corpus luteum: developmental expression and hormonal regulation in pregnancy. Endocrinology. 138: 4812-20. PMID 9348210 DOI: 10.1210/Endo.138.11.5479 |
0.327 |
|
| 1997 |
Sugino N, Telleria CM, Gibori G. Progesterone inhibits 20alpha-hydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor. Endocrinology. 138: 4497-500. PMID 9322971 DOI: 10.1210/Endo.138.10.5572 |
0.365 |
|
| 1995 |
Carrizo DG, Rastrilla AM, Tellería CM, Aguado LI. Androstenedione stimulates progesterone production in corpora lutea of pregnant rats: an effect not mediated by oestrogen. The Journal of Steroid Biochemistry and Molecular Biology. 51: 191-7. PMID 7981128 DOI: 10.1016/0960-0760(94)90093-0 |
0.383 |
|
| 1995 |
Telleria CM, Deis RP. Effect of RU486 on ovarian progesterone production at pro-oestrus and during pregnancy: a possible dual regulation of the biosynthesis of progesterone. Journal of Reproduction and Fertility. 102: 379-84. PMID 7861391 DOI: 10.1530/Jrf.0.1020379 |
0.301 |
|
| 1994 |
Tellería CM, Carrizo DG, Deis RP. Levonorgestrel inhibits luteinizing hormone-stimulated progesterone production in rat luteal cells. The Journal of Steroid Biochemistry and Molecular Biology. 50: 161-6. PMID 8049144 DOI: 10.1016/0960-0760(94)90023-X |
0.421 |
|
| Show low-probability matches. |